Bortezomib Injection IP 2 mg is a proteasome inhibitor used in the treatment of multiple myeloma and mantle cell lymphoma. It works by blocking proteasomes, which leads to cancer cell death. This medication is administered via intravenous (IV) or subcutaneous injection under medical supervision.
Specification | Details |
---|---|
Minimum Order Quantity | 10 Vials |
Brand | Bortezomib |
Application | Treatment of Multiple Myeloma & Mantle Cell Lymphoma |
Packing Type | Glass Vial |
Gender | Men & Women |
Quantity Per Pack | 1 Vial |
Packaging Type | Box |
Packing Size | 2 mg |
Form | Injection |
Dosage Strength | 2 mg |
Usage | Intravenous |
Price: